HCPCS code J1823 — Inj. inebilizumab-cdon, 1 mg. Status: Active. Effective Jan 1, 2021. Source: CMS HCPCS Level II.

J1823

Active

Inj. inebilizumab-cdon, 1 mg

Injection, inebilizumab-cdon, 1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jan 1, 2021
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9394

MUE — Medically Unlikely Edits

Maximum units of J1823 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 300
Practitioner Services 300

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
75987-0150-03 Uplizna

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2021-Q1
    Inj. inebilizumab-cdon, 1 mg